Digital Content 
NEWS #PharmaBuzz
28 Jun 2022
// Gabrielle Masson FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/unable-hit-licensing-deal-terms-basilea-will-return-cancer-drug-rights-merck
13 Apr 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/04/13/2421542/0/en/Basilea-reports-preclinical-data-on-oncology-drug-candidates-BAL0891-derazantinib-and-lisavanbulin-at-AACR-Annual-Meeting.html
24 Jan 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/01/24/2371306/0/en/Basilea-reports-updated-interim-results-for-iCCA-patients-with-FGFR2-mutations-and-amplifications-from-phase-2-study-FIDES-01-at-ASCO-GI-Cancers-Symposium.html
11 Oct 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/10/11/2311499/0/en/Basilea-presents-preclinical-data-on-synergy-between-derazantinib-and-paclitaxel-in-gastric-tumor-models-at-ANE-Conference.html
17 Sep 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/09/17/2298839/0/en/Basilea-presents-full-safety-and-efficacy-data-set-on-derazantinib-in-patients-with-FGFR2-fusion-positive-iCCA-at-ESMO-congress.html
26 Oct 2020
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2020/10/26/2113997/0/en/Basilea-presents-preclinical-data-on-anti-angiogenic-activity-of-derazantinib-at-ENA-2020.html#:~:text=Filings%20Media%20Partners-,Basilea%20presents%20preclinical%20data%20on%20anti%2Dangiogenic,of%20derazantinib%20at%20ENA%202020&text=Basilea%20Pharmaceutica%20Ltd.&text=The%20presented%20data%20from%20several,activity%20in%20FGFR%2Ddriven%20cancers.
LOOKING FOR A SUPPLIER?
Share